Trial Profile
Trabectedin as second-line therapy for advanced translocation-related sarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2016
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 14 Sep 2015 According to a PharmaMar media release, data from this study will be presented at the 18th ECCO - 40th ESMO European Cancer Congress (ECC 2015).
- 30 Mar 2015 New trial record